138 results
Page 2 of 7
8-K
EX-99.2
j3nxop9f21ou2
24 Feb 21
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
5:29pm
8-K
EX-99.1
xwz 9xf06b7diw5v
24 Feb 21
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
5:29pm
8-K
exouxa tzxr63dk2
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.1
wa4ol crfbx2u2h
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.2
8qv63kt 03
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.3
bqlv zr9rssrg17oocm
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm